Jazz Pharmaceuticals plc - SHS USD (JAZZ)

CUSIP: G50871105

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Equity / SHS USD
Total 13F shares
53,141,372
Share change
+2,279,313
Total reported value
$8,263,546,157
Put/Call ratio
84%
Price per share
$155.50
Number of holders
314
Value change
+$374,758,650
Number of buys
162
Number of sells
136

Quarterly Holders Quick Answers

What is CUSIP G50871105?
CUSIP G50871105 identifies JAZZ - Jazz Pharmaceuticals plc - SHS USD in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of JAZZ - Jazz Pharmaceuticals plc - SHS USD (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
PUTNAM INVESTMENTS LLC
13F
Company
class O/S missing
7,846,512
$1,138,764,000 31 Mar 2017
13F
FMR LLC
13F
Company
class O/S missing
7,441,062
$1,079,921,000 31 Mar 2017
13F
VANGUARD GROUP INC
13F
Company
class O/S missing
4,523,315
$656,469,000 31 Mar 2017
13F
BlackRock Finance, Inc.
13F
Company
class O/S missing
3,215,159
$466,615,000 31 Mar 2017
13F
JANUS HENDERSON INVESTORS US LLC
13F
Company
class O/S missing
1,470,245
$213,367,000 31 Mar 2017
13F
Bank of New York Mellon Corp
13F
Company
class O/S missing
1,447,760
$210,114,000 31 Mar 2017
13F
WESTFIELD CAPITAL MANAGEMENT CO LP
13F
Company
class O/S missing
1,377,214
$199,875,000 31 Mar 2017
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
class O/S missing
1,225,000
$177,784,000 31 Mar 2017
13F
CADIAN CAPITAL MANAGEMENT, LP
13F
Company
class O/S missing
1,218,763
$176,879,000 31 Mar 2017
13F
FIL Ltd
13F
Company
class O/S missing
1,203,381
$174,646,000 31 Mar 2017
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
class O/S missing
1,160,963
$168,491,000 31 Mar 2017
13F
CITADEL ADVISORS LLC
13F
Company
class O/S missing
1,138,703
$165,260,000 31 Mar 2017
13F
JPMORGAN CHASE & CO
13F
Company
class O/S missing
995,377
$144,460,000 31 Mar 2017
13F
PFM Health Sciences, LP
13F
Company
class O/S missing
864,276
$125,432,000 31 Mar 2017
13F
Senator Investment Group LP
13F
Company
class O/S missing
750,000
$108,848,000 31 Mar 2017
13F
STATE STREET CORP
13F
Company
class O/S missing
728,770
$105,779,000 31 Mar 2017
13F
AMUNDI ASSET MANAGEMENT US, INC.
13F
Company
class O/S missing
708,876
$102,879,000 31 Mar 2017
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
class O/S missing
663,548
$96,301,000 31 Mar 2017
13F
NORGES BANK
13F
Company
class O/S missing
652,106
$94,640,000 31 Mar 2017
13F
WELLS FARGO & COMPANY/MN
13F
Company
class O/S missing
503,759
$73,111,000 31 Mar 2017
13F
FRANKLIN RESOURCES INC
13F
Company
class O/S missing
418,331
$60,713,000 31 Mar 2017
13F
ROYAL BANK OF CANADA
13F
Company
class O/S missing
396,719
$57,576,000 31 Mar 2017
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
class O/S missing
393,263
$57,049,000 31 Mar 2017
13F
MORGAN STANLEY
13F
Company
class O/S missing
381,092
$55,309,000 31 Mar 2017
13F
Point72 Asset Management, L.P.
13F
Company
class O/S missing
376,904
$54,700,000 31 Mar 2017
13F
ORBIMED ADVISORS LLC
13F
Company
class O/S missing
371,400
$53,901,000 31 Mar 2017
13F
UBS Group AG
13F
Company
class O/S missing
338,433
$49,116,000 31 Mar 2017
13F
Tekla Capital Management LLC
13F
Company
class O/S missing
331,411
$48,098,000 31 Mar 2017
13F
TEACHERS ADVISORS, LLC
13F
Company
class O/S missing
326,917
$47,445,000 31 Mar 2017
13F
GOLDMAN SACHS GROUP INC
13F
Company
class O/S missing
320,203
$46,471,000 31 Mar 2017
13F
KBC Group NV
13F
Company
class O/S missing
312,661
$45,376,000 31 Mar 2017
13F
APG Asset Management N.V.
13F
Company
class O/S missing
304,689
$44,220,000 31 Mar 2017
13F
BNP Paribas Asset Management Holding S.A.
13F
Company
class O/S missing
275,934
$40,046,000 31 Mar 2017
13F
Invesco Ltd.
13F
Company
class O/S missing
263,175
$38,195,000 31 Mar 2017
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
class O/S missing
235,806
$34,223,000 31 Mar 2017
13F
Legal & General Group Plc
13F
Company
class O/S missing
226,345
$32,849,000 31 Mar 2017
13F
WADDELL & REED FINANCIAL INC
13F
Company
class O/S missing
225,358
$32,706,000 31 Mar 2017
13F
Brandywine Global Investment Management, LLC
13F
Company
class O/S missing
219,740
$31,891,000 31 Mar 2017
13F
NORTHERN TRUST CORP
13F
Company
class O/S missing
218,301
$31,683,000 31 Mar 2017
13F
Swiss National Bank
13F
Company
class O/S missing
212,300
$30,811,000 31 Mar 2017
13F
STRS OHIO
13F
Company
class O/S missing
211,900
$30,753,000 31 Mar 2017
13F
DEUTSCHE BANK AG\
13F
Company
class O/S missing
202,726
$29,418,000 31 Mar 2017
13F
VIKING GLOBAL INVESTORS LP
13F
Company
class O/S missing
197,830
$28,711,000 31 Mar 2017
13F
Tourbillon Capital Partners, L.P.
13F
Company
class O/S missing
192,407
$27,924,000 31 Mar 2017
13F
AMERIPRISE FINANCIAL INC
13F
Company
class O/S missing
181,404
$26,328,000 31 Mar 2017
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
class O/S missing
175,220
$25,430,000 31 Mar 2017
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
class O/S missing
159,091
$23,089,000 31 Mar 2017
13F
TWO SIGMA ADVISERS, LP
13F
Company
class O/S missing
157,757
$22,895,000 31 Mar 2017
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
class O/S missing
154,195
$22,378,000 31 Mar 2017
13F
OppenheimerFunds, Inc.
13F
Company
class O/S missing
150,840
$21,891,000 31 Mar 2017
13F

Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q2 2017

As of 30 Jun 2017, Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by 314 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 53,141,372 shares. The largest 10 holders included PUTNAM INVESTMENTS LLC, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., JPMORGAN CHASE & CO, CADIAN CAPITAL MANAGEMENT, LP, Bank of New York Mellon Corp, WESTFIELD CAPITAL MANAGEMENT CO LP, RENAISSANCE TECHNOLOGIES LLC, and FIL Ltd. This page lists 314 institutional shareholders reporting positions in this security for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2017 vs Q1 2017 Across Filers

Q1 2017 holders
302
Q2 2017 holders
314
Holder diff
12
Investor Q1 2017 Shares Q2 2017 Shares Share Diff Share Chg % Q1 2017 Value $ Q2 2017 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.